NTLA
Price
$7.23
Change
+$0.37 (+5.39%)
Updated
Apr 17 closing price
Capitalization
748.43M
12 days until earnings call
TNYA
Price
$0.45
Change
-$0.01 (-2.17%)
Updated
Apr 17 closing price
Capitalization
73.16M
18 days until earnings call
Ad is loading...

NTLA vs TNYA

Header iconNTLA vs TNYA Comparison
Open Charts NTLA vs TNYABanner chart's image
Intellia Therapeutics
Price$7.23
Change+$0.37 (+5.39%)
Volume$2.87M
Capitalization748.43M
Tenaya Therapeutics
Price$0.45
Change-$0.01 (-2.17%)
Volume$1M
Capitalization73.16M
NTLA vs TNYA Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. TNYA commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and TNYA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (NTLA: $7.23 vs. TNYA: $0.45)
Brand notoriety: NTLA and TNYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 79% vs. TNYA: 26%
Market capitalization -- NTLA: $748.43M vs. TNYA: $73.16M
NTLA [@Biotechnology] is valued at $748.43M. TNYA’s [@Biotechnology] market capitalization is $73.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileTNYA’s FA Score has 1 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • TNYA’s FA Score: 1 green, 4 red.
According to our system of comparison, both NTLA and TNYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while TNYA’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 3 bearish.
  • TNYA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than TNYA.

Price Growth

NTLA (@Biotechnology) experienced а +6.79% price change this week, while TNYA (@Biotechnology) price change was +2.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

NTLA is expected to report earnings on Jul 31, 2025.

TNYA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($748M) has a higher market cap than TNYA($73.2M). NTLA YTD gains are higher at: -37.993 vs. TNYA (-68.531). TNYA has higher annual earnings (EBITDA): -107.48M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. TNYA (61.4M). TNYA has less debt than NTLA: TNYA (13.6M) vs NTLA (210M). NTLA has higher revenues than TNYA: NTLA (57.9M) vs TNYA (0).
NTLATNYANTLA / TNYA
Capitalization748M73.2M1,022%
EBITDA-523.98M-107.48M488%
Gain YTD-37.993-68.53155%
P/E RatioN/AN/A-
Revenue57.9M0-
Total Cash602M61.4M980%
Total Debt210M13.6M1,544%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLATNYA
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+5.39%
CRSP - NTLA
66%
Closely correlated
-0.03%
BEAM - NTLA
63%
Loosely correlated
+2.29%
RXRX - NTLA
61%
Loosely correlated
+3.38%
ABCL - NTLA
58%
Loosely correlated
+1.26%
RCKT - NTLA
58%
Loosely correlated
+2.93%
More

TNYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with ABSI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
-2.58%
ABSI - TNYA
35%
Loosely correlated
+1.31%
RCUS - TNYA
34%
Loosely correlated
+0.38%
OPT - TNYA
32%
Poorly correlated
N/A
FATE - TNYA
32%
Poorly correlated
+5.71%
NTLA - TNYA
31%
Poorly correlated
+5.39%
More